Home > Insider Trading > Filing (0001019687-13-002730)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1355790	International Stem Cell Corp	ISCO:OB	Pharmaceutical Preparations (2834)	204494098

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1447708	Andrey Semechkin	C/O International Stem Cell Corp. 5950 Priestly Drive Carlsbad CA 92008	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-24	5,998,999	$0.15	18,536,799	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrant (Right to Buy)	Acquisiton	2013-07-24	5,998,999	$0.00	5,998,999	$0.15
See Footnote	Series B Warrant (4) (Right to Buy)	Acquisiton	2013-07-24	5,998,999	$0.00	11,997,998	$0.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,998,999	2013-07-24	2018-07-24	No	4	P	Direct
5,998,999	2013-07-24	2013-10-23	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,000,000	Indirect	By Corporation

Footnotes

Common Stock is owned by X-Master, Inc., a New Hampshire Corporation of which the reporting person is a director and sole shareholder.
Exercise price is initially set at $0.15 per share, subject to adjustments in the event of certain transactions as defined in the warrant agreement.
Exercise price is subject to adjustment and is initially set at $0.15 per unit. On the Adjustment Date (as defined in the warrant agreement) the exercised price will be reduced to 80% of the closing bid price of the Issuer's common Stock on the adjustment date (if that is lower than the then current exercise price) . Additionally, the exercise price is subject to further adjustments in the event of certain transactions as defined in the warrant agreement.
Exercisable for Units. Each Unit consists of one share of common stock of the company and one Series A Warrant.
Assuming full exercise of the Series A Warrants issued on exercise of the Series B Warrants. Number of underlying securities issuable under the warrants is subject to a 4.999% beneficial ownership limitation; except for in the event of a fundamental transaction (as defined in the warrant agreement) the beneficial ownership limitation is set at 9.99%.